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Abstract
Foxp3+ regulatory T cells (Tregs) are required for immune homeostasis. One notable distinction 
between conventional T cells (Tconv) and Tregs is differential phosphatidylinositol 3-kinase (PI3K) 
activity: only Tconv downregulate PTEN, the primary negative regulator of PI3K, upon activation. 
Here, we show that control of PI3K in Tregs is essential for lineage homeostasis and stability. Mice 
lacking Pten in Tregs developed an autoimmune-lymphoproliferative disease characterized by 
excessive TH1 responses and B cell activation. Diminished control of PI3K activity in Tregs led to 
reduced CD25 expression, accumulation of Foxp3+CD25− cells and ultimately, loss of Foxp3 
expression in these cells. Collectively, these data demonstrate that control of PI3K signaling by 
PTEN in Tregs is critical to maintain their homeostasis, function and stability.
Regulatory T cells (Tregs) defined by expression of the transcription factor Foxp3 are 
required for normal immune homeostasis. Mutation of the Foxp3 gene in mouse and human 
leads to the scurfy phenotype and IPEX disease, respectively, both characterized by the lack 
of functional Tregs, autoimmunity, and systemic polyclonal lymphoproliferation1, 2. This 
central role of Tregs in immune tolerance has led to a focus on defining the signals that 
govern Treg generation, function and stability3. Critical among these signals are those 
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delivered by the interleukin 2 receptor (IL-2R), as enhancement of IL-2R signaling 
dramatically expands Tregs in vivo4. Among the signals activated via the IL-2R, 
phosphorylation of STAT5 appears to be particular important for Treg maintenance and 
expansion5.
In addition to activation of STAT5, IL-2 also initiates signaling through phosphatidylinositol 
3-kinase (PI3K), which can be activated as well via the TCR or CD286, 7. The primary 
negative regulator of PI3K is phosphatase and tensin homolog on chromosome 10 (PTEN), a 
lipid phosphatase, which catalyzes the reverse reaction of PI3K8. Demonstrating the 
importance of PI3K regulation in immune homeostasis, animals harboring one inactive 
PTEN allele, develop systemic autoimmunity, which has been attributed in part to defects in 
thymic negative selection, as well as in Fas-mediated and activation-induced cell death in 
potential effector T cells. While T cell-specific PTEN deficiency leads to a lethal CD4+ T 
cell lymphoma of thymic origin7, 9, 10, when lymphoma development is prevented by early 
thymectomy, systemic autoimmunity is observed, indicating that targeting PTEN in T cells 
is sufficient to disturb self-tolerance.
We and others, have previously shown that regulatory T cells, but not effector T cells, 
maintain high amounts of PTEN expression, thus preventing the downstream activation of 
PI3K targets following IL-2 stimulation, while allowing further JAK-STAT signaling11, 12. 
Indeed, control of PTEN via the scaffold protein Disc large homolog 1 is critical for human 
Treg function in vitro13. This suggests that Tregs require a mechanism of PI3K control 
distinct from effector T cells.
Consistent with this notion, PI3K signaling inhibits in vitro Treg differentiation and 
homeostasis, while rapamycin promotes Treg proliferation and accumulation in the 
periphery14–18. Conversely, pharmacological inhibition of PI3K signaling enhances in vitro 
Treg differentiation14, 19 and expression of a constitutively active Akt allele in Tregs leads to 
an overall dampening of the Treg gene signature, including reduced expression of Foxp3, 
Il2ra (CD25), and Ctla416.
To define the cell-intrinsic function of the PI3K pathway in Treg homeostasis, we generated 
mice lacking expression of PTEN specifically within the Foxp3+ population, termed Pten-
ΔTreg mice. Disruption of PTEN did not result in catastrophic decreases in Foxp3+ Tregs; in 
fact, there was an increase in the CD25− subset of Foxp3+ cells. However, despite the 
continued presence of the Foxp3+ Treg population, Pten-ΔTreg mice developed a systemic 
polyclonal lymphoproliferative disease and renal failure. Female mice heterozygous for 
Foxp3-Cre were initially healthy, but over time their wild-type Treg compartment was 
replaced by PTEN-deficient Tregs, and they ultimately succumbed to disease. Further studies 
revealed that loss of PTEN was associated with disruptions in cellular metabolism and 
energy utilization. Finally, we found that elevation of PI3K signaling in PTEN-deficient 
regulatory T cells led directly to the successive loss of CD25 followed by Foxp3, and the 
emergence of ‘ex’-Foxp3 cells (i.e., cells which were once Foxp3+ but appear to have 
permanently lost Foxp3 expression). Together, these data show that control of PI3K 
signaling via PTEN is required to maintain Treg homeostasis, function and Foxp3 
expression.
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Results
Generation of Pten-ΔTreg mice
Ptenfl/fl and Foxp3-Cre mice were crossed to generate Pten-ΔTreg mice, which lack PTEN 
expression specifically in the Foxp3+ population of cells (Fig. 1a). Unlike animals lacking 
PTEN in all T cells19, Pten-ΔTreg mice developed an expanded Treg population in multiple 
tissues at young ages, while maintaining normal T cell development (Fig. 1b, Supplementary 
Fig. 1a). Though these PTEN-deficient Tregs were generally phenotypically normal 
(Supplementary Fig. 1b), they expressed substantially lower amounts of the high-affinity 
IL-2 receptor subunit, CD25, than did control Pten+/+ Foxp3-Cre Tregs (Fig. 1c). To exclude 
the possibility that downregulation of CD25 was a consequence of unappreciated 
developmental abnormalities, we used a tamoxifen-inducible system to delete PTEN in vitro 
from pre-existing Foxp3+ cells. Deletion of PTEN led to a marked reduction in CD25 
expression (Fig. 1d), thus demonstrating that PTEN deletion is sufficient to downregulate 
CD25 in otherwise normal Tregs.
Development of disease in Pten-ΔTreg mice
Despite their enlarged Treg compartment, Pten-ΔTreg mice developed peripheral 
lymphoproliferative disease (defined as grossly visible lymphadenopathy) with age (Fig. 2a) 
that appeared as early as 12 weeks of age, and by 28 weeks of age affected approximately 
80% of animals. While lymphoproliferation affected secondary lymphoid tissue, thymic 
cellularity was not increased, most likely due to the affects of autoimmunity (see below) 
with B cell infiltration of the thymus (data not shown). Interestingly, the lymphocyte 
compartments of diseased Pten-ΔTreg mice were notable for a further increase in the 
population of Foxp3+CD25− cells compared to healthy mice, and a large expansion of 
activated CD4+CD44hiCD62Llo T cells (Fig. 2b). Expanded CD44hiCD62Llo cells were 
seen within the Treg compartment itself, in association with elevated ICOS expression (Fig. 
2c).
We observed a large accumulation of germinal center B cells in both healthy and diseased 
Pten-ΔTreg mice (Supplementary Fig. 2a), accompanied by high concentrations of serum 
IgG1, IgG2a/c and IgG2b, and a decrease in IgG3 in diseased mice (Fig. 2d). Consistent 
with elevations in immunogloblulin concentrations, Pten-ΔTreg mice had marked increases 
in TFH cell numbers (defined as CD4+ICOS+CXCR5+Foxp3− cells) in the spleen 
(Supplementary Fig. 2b). Increases in TFR cell numbers were also observed (Supplementary 
Fig. 2b), consistent with the general increases in Treg cell numbers observed in Pten-ΔTreg 
mice. In addition, when conventional T cells from diseased Pten-ΔTreg mice were stimulated 
ex vivo, a large population of IFN-γ producing cells was detected (Fig. 2e). There was no 
increase in IL-17 production from T cells isolated from either spleen, mesenteric lymph 
node or colonic lamina propria (Fig. 2e and data not shown). Consistent with this, both Tregs 
and conventional T cells isolated from Pten-ΔTreg mice had elevated expression of the 
chemokine receptor CXCR3, which promotes cell homing to sites of TH1-type inflammation 
(Supplementary Fig. 2c)20. These data collectively suggest that Pten-ΔTreg mice develop a 
TH1-type lymphoproliferative disease involving both T and B cells.
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Most visceral organs from aged and visibly ill Pten-ΔTreg mice had normal gross and 
histologic appearance (data not shown), with the notable exception of the kidneys (Fig. 2f), 
which revealed a proliferative glomerulonephritis, interstitial infiltrates and cortical atrophy. 
This histologic picture was accompanied by elevations in serum concentrations of anti-
double stranded DNA antibodies and creatinine (Fig. 2g,h). The rise in serum creatinine 
concentrations corresponded temporally with the onset of visible lymphadenopathy, 
indicating that kidney failure and autoimmunity occurred concomitantly. As with secondary 
lymphoid organs, we found a large population of Foxp3+CD25− cells within the diseased 
kidneys (Supplementary Fig. 2d).
As PTEN deletion in T cells and non-lymphoid cells can lead to malignancy in mice and 
humans9, 21, we addressed the possibility that Pten-ΔTreg mice had developed malignant 
disease rather than autoimmunity. One characteristic of autoimmunity in thymectomized 
Pten-ΔT mice is the maintenance of normal TCR Vβ diversity, while PTEN-null T cell 
malignancies are monoclonal10. We found comparable TCR Vβ diversity in both naïve 
CD4+ cells and Treg isolated from diseased mice, strongly suggesting that the hyperplastic 
cells were not malignant (Supplementary Fig. 2e). Finally, the expanded population of T 
cells also predominantly expressed low amounts of CD24 (HSA), in contrast with what is 
observed in PTEN-deficient T cell malignancies, which, like thymocytes, are CD24hi 
(Supplementary Fig. 2e)10, 22. Thus the expanded population of T cells in Pten-ΔTreg mice is 
a polyclonal non-malignant population.
Defective regulation by PTEN-deficient Tregs
As we observed elevated numbers of Tregs in Pten-ΔTreg mice, we next used BrdU labeling 
to assess their in vivo proliferative capacity. While PTEN-deficient Foxp3+CD25+ Tregs 
were more proliferative than wild-type controls, BrdU incorporation was highest in the 
Foxp3+CD25− Treg subset (Fig. 3a). Interestingly, these proliferative differences in 
Foxp3+CD25+ and Foxp3+CD25− cells were seen in both Pten-ΔTreg mice as well as wild-
type controls (Fig. 3a). To further assess the in vivo maintenance of PTEN-deficient Tregs, 
we utilized the X-linked nature of the Foxp3-Cre knock-in transgene and bred female 
Ptenfl/fl mice to be heterozygous for Foxp3-Cre23. Due to random X-inactivation, Foxp3-Cre 
heterozygous females should maintain a 50:50 ratio of Cre+YFP+ PTEN-deficient 
Tregs:Cre−YFP− PTEN-sufficient wild-type Tregs. This was the case in young Cre 
heterozygous mice, which did not develop activated T cell accumulation at the same time as 
their Pten-ΔTreg counterparts. However, over time, we found that the PTEN-deficient Tregs 
were increased in number relative to wild-type Tregs in the blood and lymph nodes of Foxp3-
Cre heterozygous females (Fig. 3b and data not shown), and this was accompanied by the 
eventual onset of disease (Fig. 3c,d), presumably due to the loss of wild-type Tregs.
From these data, we hypothesized that the lymphoproliferative disease seen in Pten-ΔTreg 
mice could result from three distinct, but non-mutually exclusive processes: PTEN-deficient 
Tregs were unable to perform normal regulatory functions and control effector T cell 
responses; PTEN deletion caused Treg lineage instability, therefore generating pathogenic 
PTEN-deficient effector cells; and transient expression of Foxp3 by non-Tregs caused 
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aberrant excision of PTEN, leading to the generation of pathogenic PTEN-deficient non-
Tregs.
We first excluded the possibility of transient expression of Foxp3 in non-Tregs leading to 
Cre-mediated Pten excision by assessing Pten recombination status at the genomic locus in 
sorted cell populations from young, healthy Pten-ΔTreg mice (Supplementary Fig. 3)24. 
Using primers to specifically detect the deleted Pten locus, we found that recombination of 
Pten was only seen in Foxp3+ populations and in neither naïve nor activated T cells, 
indicating that Cre-mediated Pten excision was faithful and confined to the Foxp3+ Treg 
population.
Next, we used the experimental autoimmune encephalomyelitis (EAE) model to analyze the 
in vivo functional capacity of PTEN-deficient Tregs. We found that while the initial onset of 
disease was similar in Pten-ΔTreg and wild-type mice, Pten-ΔTreg mice were unable to 
spontaneously resolve the disease, a process which has previously been shown to be Treg 
dependent25. Notably, progression of symptoms in Pten-ΔTreg mice occurred despite the 
mice maintaining high numbers of Foxp3+ cells in secondary lymphoid organs as well as in 
the brain itself (Fig. 4a,b), and as would be anticipated, disease severity was accompanied 
by increased production of IFN-γ and IL-17 by effector T cells (Fig. 4c). Interestingly, 
however, we found that Foxp3+ cells in Pten-ΔTreg mice produced IL-17 to a similar degree 
as did non-Tregs (Fig. 4c), suggesting that these PTEN-deficient Tregs might be pathogenic in 
vivo.
The apparent functional defects of PTEN-deficient Foxp3+ cells in our in vivo models led to 
the question of whether these cells were bona fide Tregs. We performed transcriptional 
analysis on PTEN-deficient Foxp3+CD25+ and Foxp3+CD25− cells and found that both 
populations of PTEN-deficient Tregs maintained normal expression of Treg signature 
genes26 including Foxp3, Ctla4 and Nrp1 (Supplementary Fig. 4). Collectively, these data 
show that Pten-ΔTreg mice were unable to resolve the inflammatory insult of EAE, despite 
the continued presence of high numbers of Tregs.
Elevated glycolytic activity in PTEN-deficient Tregs
Metabolic programming may dictate T cell fate decisions that occur during differentiation27; 
PI3K activity promotes glycolytic metabolism in various cell types including conventional T 
cells28, while in contrast Tregs favor oxidative metabolism to meet their energy demands29. 
Strikingly, we observed that Tregs from Pten-ΔTreg mice had a much higher glucose-
stimulated increase in extracellular acidification rate (ECAR – an indirect measurement of 
glycolysis), compared to wild-type Tregs (Fig. 5b). The mitochondrial ATP synthase 
inhibitor oligomycin did not further increase ECAR but decreased the oxygen consumption 
rate (OCR – an indicator of mitochondrial respiration), suggesting that maximal glycolytic 
capacity was reached by the initial addition of glucose in both populations (data not shown). 
The return of ECAR to basal levels in response to the addition of 2-deoxy-glucose indicates 
that glucose-stimulated changes in ECAR were due to glycolysis (Fig. 5b). In contrast to 
this, the ATP coupled respiration and the spare respiratory capacity (SRC) of PTEN-
deficient Tregs as measured by the OCR, after addition of oligomycin and FCCP respectively 
was similar to that of wild-type Tregs (Fig. 5c). Further, addition of etomoxir, which blocks 
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mitochondrial fatty acid oxidation, followed by rotenone and antimycin (to block complex-I 
and complex-III of the electron transport chain respectively) reduced the SRC in both 
PTEN-deficient Tregs and wild-type Tregs to a similar degree (Fig. 5c). This overlapping 
mitochondrial profile between the two populations suggests that mitochondrial function was 
unimpaired in Tregs in the absence of PTEN. Finally, to independently confirm the increase 
in glycolytic metabolism of Pten-ΔTreg cells, we measured their glycolytic rate via assessing 
the generation of 3H2O from [3-3H]-glucose. Consistent with our Seahorse data, we found 
that Pten-ΔTreg cells possessed a higher glycolytic rate than their wild-type counterparts 
upon activation (Fig. 5d). Together, these findings indicate that PTEN deficiency in Tregs 
renders them hyperglycolytic, a bioenergetic state that could disrupt their homeostasis and 
cause functional instability.
PTEN-deficient Tregs are unstable
While the severity of EAE-related inflammation in Pten-ΔTreg mice as well as the ultimate 
development of autoimmune disease onset in Cre heterozygous females may be a result of 
an inherent inability of PTEN-deficient Tregs to perform normal regulatory function, these 
data could also indicate compromised stability of PTEN-deficient Tregs, particularly during 
inflammatory settings. One potential marker of Treg instability as a result of PTEN loss 
would be methylation of the Treg-specific demethylated region (TSDR)30. Methylation of 
the Foxp3 locus has been associated previously with maintenance of Foxp3 expression and 
resultant Treg stability30. Therefore, we analyzed TSDR methylation in Foxp3+CD25+ and 
Foxp3+CD25− cells purified by sorting from wild-type and Pten-ΔTreg mice. We observed a 
moderate reduction of TSDR demethylation in CD25+ PTEN-deficient Tregs compared to 
wild-type CD25+ Tregs (Fig. 6). Interestingly, a similar “loss” of demethylation was 
observed in both populations of Foxp3+CD25− Tregs, which is consistent with lower 
expression of Foxp3 protein in both wild-type and PTEN-deficient CD25− Tregs (31–33 and 
Supplementary Fig. 5).
To more directly evaluate PTEN-deficient Treg stability, sort purified in vitro-induced 
Foxp3+CD25+ Tregs were cultured in the presence of IL-2. We observed that PTEN-deficient 
Tregs began to downregulate CD25 expression by 48h, and subsequently lost expression of 
Foxp3 (Fig. 7a). Blockade of PI3K signals prevented both CD25 and Foxp3 loss, but had no 
effect on wild-type Tregs (Fig. 7a). As loss of CD25 expression preceded loss of Foxp3, the 
Foxp3+CD25− phenotype may be an initial, and perhaps inciting, step in Treg destabilization. 
The fact that neither supplemental IL-2 nor PI3K inhibition alone was able to fully stabilize 
Foxp3 and CD25 expression (Supplementary Fig. 6a), provides further evidence for the 
importance of the proper integration and modulation of PI3K and CD25 signals in Treg 
stability.
As PI3K activation is upstream of both mTORC1 and mTORC2, we assessed the activation 
of these two arms of the mTOR pathway via the phosphorylation of their downstream 
targets S6 (mTORC1) and Akt (Serine 473, mTORC2). While PTEN-deficient Tregs 
exhibited enhanced phosphorylation of Akt both at baseline and following TCR/CD28 
stimulation, pS6 levels were not increased over control Tregs either at rest or after 
stimulation (Supplementary Fig. 6b), indicating a preferential over-activation of mTORC2. 
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Similarly, inhibition of Akt (which is activated by PI3K and mTORC2) was more effective 
than rapamycin, which primarily affects mTORC1, at restoring CD25 expression on PTEN-
deficient Tregs in vitro (Supplementary Fig. 6c).
STAT5 binds to the Foxp3 promoter, thus regulating its expression and possibly stability5. 
As CD25 downregulation preceded loss of Foxp3 expression in vitro, we assessed the 
downstream phosphorylation of STAT5 within PTEN-deficient Foxp3+CD25+ Tregs. 
Importantly, we found brief stimulation with IL-2 induced similar amounts of pSTAT5 in 
Foxp3+CD25+ cells from both Pten-ΔTreg mice and wild-type mice, demonstrating that 
elevated PI3K signaling does not alter the ability of Tregs to respond to IL-2 stimulation 
(Fig. 7b)11.
As noted above, a deleted Pten allele was only detected in Foxp3+ cells in young, healthy 
Pten-ΔTreg mice (Supplementary Fig. 3). Thus, we speculated that appearance of the 
genomic deletion in the Foxp3− population would be suggestive of PTEN-deficient Treg 
instability. In fact, we found evidence of Pten deletion at the genomic level in the activated 
CD4+ CD44hiCD62LloFoxp3− population of cells in diseased mice (Supplementary Fig. 7), 
consistent with this hypothesis. To further examine if these PTEN-deleted effector cells did 
indeed derive from bona fide Tregs, we took advantage of fate-mapping to assess and 
quantify the loss of Foxp3 in Tregs following deletion of PTEN. Ptenfl/fl mice were crossed 
to Foxp3eGFP-Cre-ERT2 Rosa26-YFP mice34 to generate Pten-iΔTreg mice. In these animals, 
treatment with tamoxifen leads to deletion of PTEN in Foxp3+ cells, which are 
simultaneously “marked” by excision of a stop codon in the ubiquitously expressed Rosa26 
locus, allowing the transcription and expression of YFP. While in theory, eGFP can be used 
as a surrogate for Foxp3 expression, in practice we found that the eGFP signal in the Foxp3 
locus was relatively weak compared with the much stronger YFP signal in the Rosa26 locus 
(data not shown). This, coupled with the known high degree of spectral emission overlap 
between GFP and YFP, made it simpler to assess Foxp3 expression directly by antibody 
staining while preserving Rosa26-YFP expression (Supplementary Fig. 8). A population of 
Foxp3− cells within the YFP+ population could be distinguished in the blood of both Pten-
iΔTreg mice and wild-type Foxp3eGFP-Cre-ERT2 Rosa26-YFP mice (iFoxp3-Cre) as early as 1 
week after initiation of a 5 day course of tamoxifen (Fig. 8a). Notably, by 10 weeks post-
tamoxifen treatment, the percentage of ‘ex’-Foxp3 cells in Pten-iΔTreg mice was ~30%, i.e., 
three times higher than that seen in control animals (Fig. 8a). This increase in ‘ex’-Foxp3 
cells persisted for as long as 18 weeks post-tamoxifen (the last time point at which animals 
were bled). Confirming data from female Pten-ΔTreg mice heterozygous for Foxp3-Cre, 
reduction of CD25 expression was specific for Tregs in which PTEN was deleted (Fig. 8b). 
As ‘ex’-Foxp3 cells were observed in both control and Pten-iΔTreg mice, we also examined 
their expression of CD25, and found similar reductions in CD25 expression following loss 
of Foxp3 in both animals (Fig. 8c). Collectively, these data indicate that PTEN is important 
for the maintenance of Treg CD25 expression and Treg stability in vivo.
Discussion
The data presented in this manuscript, together with another group35, demonstrate that 
PTEN-mediated control of PI3K activity is critical for the function and stability of murine 
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Foxp3+ regulatory T cells. Disruption of PTEN results in reduced CD25 expression, the 
accumulation of Foxp3+CD25− cells, and ultimately, the loss of Foxp3 expression. Prior to 
the discovery and characterization of the Foxp3 transcription factor, high expression of 
CD25 was used to demarcate Tregs from effector T cells. As such, little relevance has been 
attributed to the small portion of Foxp3+ cells with low CD25 expression, and they have 
only been assessed in minimal detail compared to canonical Foxp3+CD25+ cells. Here, we 
have identified a population of Foxp3+CD25− cells in Pten-ΔTreg mice, which appear to be 
intermediates during the complete destabilization of canonical Foxp3+CD25+ Tregs. 
Accordingly, these Foxp3+CD25− “Treg” cells displayed a transitional phenotype, where 
their Treg transcriptional profile was maintained despite a partially methylated Foxp3 TSDR, 
consistent with their lower Foxp3 protein expression.
We observed nearly normal CD25 expression in newly-generated PTEN-deficient Tregs in 
the thymus, suggesting that the destabilization process occurred after the generation of 
canonical Tregs expressing high levels of CD25. Strikingly, the small population of 
Foxp3+CD25− “Tregs” present in wild-type mice was seen to have much the same 
transcriptional profile as their PTEN-deficient counterparts. It is possible that loss of PTEN 
expression causes proliferation and/or confers a survival advantage upon a normal 
population of unstable Foxp3+CD25− cells, which are non-pathogenic in wild-type mice 
either due to proper regulation by Foxp3+CD25+ Tregs or because they are short-lived. 
Alternatively, the large population of Foxp3+CD25−ICOS+ cells in Pten-ΔTreg mice could 
be an expanded population of effector Tregs (eTR), which have been reported to express low 
CD25 at the steady state and require ICOS rather than IL-2 for maintenance36. Interestingly, 
inflammation has been shown to drive the proliferation of eTR and skew cells away from a 
cTR phenotype36. This finding, along with our data above, suggest that PTEN loss may be 
crucial in either eTR differentiation or maintenance.
The functional stability of Tregs remains a controversial issue, with several conflicting 
reports regarding the existence, origin and physiological/pathological role of unstable 
Tregs31, 32, 34, 37, 38. Recently, non-Treg cells have been demonstrated to transiently express 
Foxp3 upon activation, thus generating a small population of ‘ex’-Foxp3 cells, which are not 
‘ex’-Tregs31. These data indicated that the Treg lineage itself was stable, but “unfaithful” 
expression of Foxp3 may occur, leading to a population of cells with unstable Foxp3 
expression. However, the loss of Foxp3 in bona fide Tregs occurs in multiple autoimmune 
settings32, 38. Activated by self-antigen, these destabilized Tregs acquired effector function 
and pathogenicity in models of autoimmunity. Consistent with these findings, we find no 
evidence that PTEN deletion is occurring in non-Tregs. We show that ‘ex’-Foxp3 cells may 
also be generated from bona fide Foxp3+CD25+ Tregs that lack PTEN in a stepwise manner 
in vitro, with loss of CD25 preceding loss of Foxp3. Finally, using lineage reporter mice, we 
observe that the basal rate of generation of ‘ex’-Foxp3 cells from Tregs in vivo increases 
approximately three-fold when PTEN is absent.
Despite a normal transcriptional profile compared to PTEN-sufficient Tregs, Foxp3+CD25− 
cells expressed lower Foxp3 protein than canonical Foxp3+CD25+ Tregs, suggesting that the 
Foxp3+CD25− Treg population may be enriched for cells with unstable Foxp3 expression. 
Interestingly, this difference in Foxp3 expression was observed in wild-type Tregs as well as 
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in PTEN-deficient Tregs; this association of Foxp3 and CD25 expression has been seen by 
other groups previously31–33.
The etiology of lymphoproliferation and autoimmunity in Pten-ΔTreg mice may be 
multifactorial. We provide evidence that PTEN-deficient Tregs exhibit lineage instability and 
can convert into Foxp3− cells. As the TCR repertoire of Tregs may be biased to self-antigen 
recognition39, this suggests the possibility that disease may be caused by conversion of 
PTEN-deficient Tregs into pathogenic effectors. Although this process of Foxp3 loss in Tregs 
occurs in wild-type mice as well, the absence of disease might be due to the comparative 
lesser degree of Treg instability and/or the fact that loss of PTEN confers an important 
survival advantage10 upon ‘ex’-Foxp3 cells. However if ‘ex’-Foxp3 cells are pathogenic, 
they must be “restrainable” by wild-type Tregs, as female mice heterozygous for Foxp3-Cre 
do not become ill until their wild-type Tregs are largely lost, and Pten-iΔTreg remain healthy 
after tamoxifen injection and resultant loss of Foxp3 in a substantial percentage of Tregs. 
Alternatively, ‘ex’-Foxp3 cells that accumulate as a result of PTEN loss may not be 
pathogenic per se, with disease in Pten-ΔTreg mice being a consequence of an intrinsic 
defect in regulation by PTEN-deficient Tregs. The inability of Pten-ΔTreg mice to resolve 
EAE in consistent with this possibility.
Activation of signaling through PI3K and mTOR inhibits peripheral Treg induction14. One 
possible mechanism for PI3K control of Tregs is via the Foxo1 and Foxo3a (Foxos) 
transcription factors, which bind to and promote Foxp3 transcription, but are inactivated by 
PI3K, 17. Indeed, deletion of Foxos severely inhibits both Treg generation and function in 
vivo, while constitutive nuclear localization of Foxos prevents these defects18. Additionally, 
the maintenance of Treg stability and function by the Neuropilin-1 (Nrp-1)/Semaphorin 4a 
(Sema4a) signaling axis is due in part to upregulation of PTEN and subsequent nuclear 
localization of Foxos upon Nrp-1 ligation40. Interestingly however, Pten-ΔTreg mice 
develop a different phenotype than animals in which Tregs lack Foxo1 expression (as the 
latter does not affect CD25− expression, nor promote inflammation induced Treg instability) 
and thus have heightened mTORC2 activation18. These disparate phenotypes suggest that 
multiple factors downstream of PTEN are critical in instructing the Treg lineage.
Modulation of PI3K signaling can alter cellular metabolism27. For example, overexpression 
of PTEN inhibits glycolysis and skews energy generation toward oxidative metabolism41. 
Interestingly, Tregs preferentially utilize lipid oxidation for energy, a process characterized 
by high AMP-activated protein kinase (AMPK) activity29. This contrasts with effector T 
cells, which primarily utilize glycolysis as a means of energy generation29, 42. Our data 
demonstrate that loss of PTEN enhances glycolysis in Tregs. The importance of metabolic 
programs in cellular activation and cell fate decisions is well recognized43, 44, including a 
role in determining if cells become in vitro induced Tregs or induced effectors29. Whether 
alterations in metabolism can affect a pre-existing lineage decision is not known, however 
the finding that Treg loss of PTEN shifts their metabolic profile suggests that this may be a 
contributing mechanism by which PTEN deletion destabilizes the Treg lineage, perhaps via 
an effect on CD25 expression, which precedes loss of Foxp3 during in vitro culture.
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T cells may express other lipid phosphatases in addition to PTEN that control PI3K signals. 
One such family, the PH-domain leucine-rich repeat protein phosphatase (PHLPP), is 
expressed at high levels in murine and human Tregs, and is required for optimal iTreg 
development and Treg function45. Our data indicate that despite the expression of additional 
lipid phosphatases in Tregs, PTEN has a non-redundant function in PI3K control and Treg 
maintenance.
The identification of PI3K as a nodal control point for Treg homeostasis is particularly 
relevant given the clinical development of PI3K inhibitors for the treatment of autoimmunity 
or cancer. In the latter arena, the target of PI3K inhibition is the tumor cell itself, although 
interestingly it was reported recently that inactivation of PI3Kδ in Tregs disabled tumor-
induced immune suppression and enabled immune-mediated tumor regression in murine 
models46. Whether PI3K blockade has a dominant role in inhibiting regulatory or effector T 
cell responses is likely to be context and dose-dependent. Our own results showing that high 
PI3K activity may cripple regulatory responses underscore the complexity of immune 
system control via this pathway.
Online methods
Mice
Ptenfl/fl 9 were bred with Foxp3-YFP-Cre knock-in mice47 provided by A. Rudensky 
(Memorial Sloan Kettering Cancer Center, New York, NY), to generate Pten-ΔTreg mice or 
with Foxp3eGFP-Cre-ERT2 Rosa26-YFP mice34– provided by A. Rudensky) to generate mice 
with tamoxifen inducible loss of PTEN in Tregs (Pten-iΔTreg mice). Control animals were 
either littermates or appropriate age/sex-matched Pten+/+Foxp3-YFP-Cre or 
Foxp3eGFP-Cre-ERT2 Rosa26YFP mice. Foxp3GFP-hCre mice48 and Rosa26cre-ER mice49 have 
been previously described. Unless otherwise stated, all figures are representative of 
experiments performed with healthy 6 – 8 week old mice. All mice were housed in specific 
pathogen-free conditions at Massachusetts General Hospital and the University of 
California, San Francisco, and all procedures were performed in accordance with protocols 
approved by each institution’s Institutional Animal Care and Use Committee.
Detection of PTEN protein and assessment of the Pten genomic locus
Specific deletion of PTEN in Foxp3+ cells at the protein level was assessed via western 
blotting as described previously23. PTEN recombination at the genomic DNA level was 
performed on highly pure sorted cell populations using previously described primers to 
specifically detect Ptenflox and deleted Pten alleles24.
Flow cytometry and cell sorting
Fluorescent anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-CD24 (30-F1), anti-CD25 (PC-61), 
anti-CD39 (Duha59), anti-CD44 (IM7), anti-CD62L (MEL-14), anti-CD73 (TY/11.8), anti-
CD122 (5H4), anti-CD132 (TUGm2), anti-CXCR3 (CXCR3-173), anti-CXCR5 (L138D7), 
anti-ICOS (7E.17G9), anti-IFN-γ (XMG1.2), anti-IL-17 (TC11-18H10.1), anti-TCRVβ2 
(B20.6) and anti-TCRVβ8 (MR5-2) antibodies were purchased from Biolegend, while anti-
PTEN (A2B1), anti-CTLA-4 (UC10-4F10-11), anti-PD-1 (29F.1A12) and anti-CD127 (SB/
Huynh et al. Page 10
Nat Immunol. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
199) fluorescent antibodies were purchased from BD Biosciences. Anti-Foxp3 intracellular 
staining kit and anti-Foxp3 (FJK-16s) antibodies were purchased from eBioscience. For 
intracellular cytokine staining, cells were restimulated with Leukocyte Activation Cocktail 
(BD Biosciences) for 5 h at 37°C. For phospho-flow cytometry, cells were serum starved at 
37°C for 1 hen activated for 15 minutes with either IL-2 (pSTAT5) or αCD3 and αCD28 
(pAkt and pS6). Cells were fixed with paraformaldehyde and permeabilized with methanol. 
Unconjugated anti-pSTAT5, anti-Akt Ser 473 and anti-S6 antibodies were purchased from 
Cell Signaling and secondary detection antibody was purchased from Jackson 
ImmunoResearch. For flow cytometric determination of PTEN, cells were stained with anti-
CD25 and anti-CD4 antibodies and then fixed and permeabilized with BD cytofix/cytoperm 
reagent to preserve endogenous YFP fluorescence. Cells were then stained with an anti-
PTEN antibody and run on LSR II flow cytometer. Cells were analyzed on a BD 
FACSCalibur, BD LSRII or Beckman Coulter Navios and sorted on a BD FACSAria II to 
over 95% purity; data were analyzed using FlowJo (Tree Star).
Treg culture conditions
Tregs were cultured in RPMI medium supplemented with 10% heat-inactivated fetal bovine 
serum, non-essential amino acids, sodium pyruvate, L-glutamine, HEPES, β-ME with 200 
(for in vitro induced Tregs) or 2,000 IU/ml (nTregs) recombinant human IL-2 (Chiron). In 
vitro induction of Foxp3 from naïve CD4+ T cells was done by stimulation of T cells with 
plate-bound anti-CD3 (0.1 μg/ml clone 145-2C11 overnight) and anti-CD28 (1 μg/ml clone 
PV-1 overnight) in the presence of 5 ng/ml TGF-β. PI3K inhibitors were used at the 
following concentrations: 10 μM LY294002, 100 nM Rapamycin, 100 nM Wortmannin, 1 
μM Akt Inhibitor VIII.
Acute deletion of PTEN in vitro
Tregs from Ptenfl/+ or Ptenfl/fl mice that also contained Rosa26-CreER were sorted by 
expression of CD4+CD25+CD62L+ and stimulated in vitro with anti-CD3 and anti-CD28 
coated beads (Dynabeads Mouse T-Activator CD3/CD28, Invitrogen). On day 4 of culture, 
cells were either treated with 500 nM 4-hydroxytamoxifen (4-OHT, Sigma) or vehicle 
(ethanol) for the duration of the experiment. CD25 expression was assessed on CD4+Foxp3+ 
cells 3 and 10 days after start of treatment.
ELISA
Serum was collected from mice via cardiac puncture for serum Igs and anti-double stranded 
DNA (anti-dsDNA) antibodies or by serial bleeding for serum creatinine. Immunoglobulin 
concentrations were detected using the eBioscience Ready-SET-Go! Mouse Ig Isotyping 
ELISA kit, creatinine concentrations were detected using an ELISA kit from US Biological 
following the manufacturer’s instructions and anti-dsDNA antibodies were detected with an 
ELISA kit from Alpha Diagnostic as per the manufacturer’s instructions.
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In vivo BrdU labeling
Mice were injected with 1 mg BrdU (BD Biosciences) i.p. every 12 h for 3 consecutive 
days. Mice were sacrificed 12 hours after the final injection and cells were stained using a 
BrdU labeling kit (BD Biosciences) following the manufacturer’s instructions.
Induction of EAE
Mice were immunized subcutaneously with MOG 35–55 peptide (UCLA Biopolymers 
Core) emulsified in Complete Freund’s Adjuvant (CFA, Difco) with M. tuberculosis 
(Difco). Additionally, mice were injected with Pertussis toxin (PT, List Biological 
Laboratories) i.p. on days 0 and 2 following immunization. Animals were evaluated daily in 
a blinded manner for signs of disease by the following criteria: 0: no disease; 1: flaccid tail 
paralysis; 2: hind limb paresis; 3: bilateral hind limb paralysis; 4: fore and hind limb 
paralysis.
Tamoxifen treatment
Foxp3eGFP-Cre-ERT2 Rosa26-YFP (iFoxp3 Cre) and Ptenfl/fl Foxp3eGFP-Cre-ERT2 Rosa26-
YFP (Pten-iΔTreg) mice were injected with 2 mg of tamoxifen (Sigma) i.p. for 5 consecutive 
days to induce Foxp3eGFP-Cre-ERT2 activity. To simultaneously detect Foxp3 by antibody 
staining while preserving Rosa-YFP fluorescence, cells were pre-fixed with 2% 
paraformaldehyde (Electron Microscopy Sciences), fixed and permeabilized using an 
eBioscience kit and stained intracellularly with an anti-Foxp3 antibody as above.
Histology
Histologic analysis was performed as previously described23.
Metabolic studies
Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were measured 
by the glycolysis-stress and mito-stress tests, respectively using the XF24 extracellular flux 
analyzer (Seahorse Bioscience). Briefly, sorted cells were rested for 20–22 hrs in the 
presence of 1ng/ml IL-2 and 5ng/ml IL-7 followed by the glycolysis-stress test that 
consisted of seeding 0.5–1 × 106 purified cells in glucose free XF Assay media onto a 24 
well XF plate coated with cell tak (BD biosciences, CN 354240) followed by sequential 
addition of glucose (20mM), oligomycin (1μM) and 2-deoxy glucose (20mM). The mito-
stress test was performed using glucose (25mM) containing XF assay media and consisted 
of sequential addition of oligomycin (1μM), FCCP(1.5μM), etomoxir (200μM) followed 
finally by rotenone (100nM) and antimycin (1μM).
The glycolytic rate was determined by measuring the conversion of 5-3H glucose to 
tritiated 3H2O as described previously50. Briefly, 0.5–1.5 × 106 purified cells were either 
unstimulated or stimulated in the presence of plate-bound anti-CD3 (5ug/ml) and anti-CD28 
(5ug/ml) and IL-2: 200U/ml. Cells were harvested between 22–24hrs, washed in 1X PBS, 
resuspended and incubated in Krebs buffer (pH 7.4, 115 mM NaCl, 2 mM KCl, 25mM 
NaHCO3, 1mM MgCl2, 0.25% BSA) for 30 min at 37°C. Following incubation, 10μCi of 
radio-labeled 5-3H glucose along with 5 μl 1M cold glucose was added to the cells and 
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incubated for another additional 1 h at 37°C. Reactions were quenched by addition of 0.5ml 
of 0.2M HCl. The diffusion chamber setup, the scintillation counting and the calculation of 
the glycolytic rate were performed as described previously50. A cell free sample with 10μCi 
of radio-labeled 5-3H glucose was included as a negative control and 0.5 μCi of radio-
labeled 3H2O was included as a positive control.
Methylation analysis of Foxp3 locus
Genomic DNA from sorted cells was bisulfite converted using the EZ DNA Methylation-
Direct kit (Zymo Research) according to the manufacturer’s protocol. Methylation-specific 
PCR primer sequences 5′-TATT TTTTTGGGTTTTGGGATATTA-3′ (forward) and 5′-
AACCAACCAACTTCCT ACACTATCTAT-3′ (reverse) were used to amplify intron 1 of 
Foxp3 (corresponding to Foxp3 CNS2). PCR products were subcloned into pGEM-T Easy 
vectors (Promega) and sequenced (9–21 sequences per mouse).
Transcriptional profiling
Foxp3+CD25+ and Foxp3+CD25− cells were double-sorted to high purity, and RNA was 
extracted with TRIzol (Life Technologies) according to the manufacturer’s instructions. 
Samples were run in triplicate using a GeneChip Mouse Gene ST 1.0 Array (Affymetrix) 
and analyzed using GENE-E, GenePattern and Gene Set Enrichment Analysis (Broad 
Institute).
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Figure 1. 
Characterization of Pten-ΔTreg mice. (a) Foxp3+ and Foxp3− cells were sort purified from 
the indicated mice and cell populations were analyzed by immunoblotting for PTEN and 
total Akt. (b) Analysis of CD4 and Foxp3 in cells isolated from the indicated tissues (pLN, 
peripheral lymph node; mLN, mesenteric lymph node). n = 10, representative of 10 
experiments; *p < 0.001, **p < 0.0001 by two-way ANOVA. (c) Expression of CD25 on 
Foxp3+ cells isolated from thymus, spleen, pLN and mLN from Pten-ΔTreg and wild-type 
mice. n = 10, representative of 10 experiments; *p < 0.05, **p < 0.01, ***p < 0.001 by two-
way ANOVA. (d) CD4+CD25+CD62L+ sorted Tregs from Ptenfl/+ or Ptenfl/fl Rosa26-CreER 
mice were cultured for the indicated times in vitro in the presence of 4-OH tamoxifen (4-
OHT) to induce Cre-mediated excision of Pten and assessed for CD25 expression. 
Representative of 2 experiments. All error bars shown are mean ± SD.
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Figure 2. 
Pten-ΔTreg mice develop spontaneous systemic lymphoproliferative disease with age. (a) 
(Left) Cell numbers from the indicated tissues of Foxp3-Cre control mice, healthy appearing 
Pten-ΔTreg mice, and diseased Pten-ΔTreg mice (as assessed by gross lymphadenopathy, 
typical age 15 – 18 weeks). n = 3 for diseased Pten-ΔTreg or 5 for other groups; 
representative of 5 experiments; *p < 0.0001, **p < 0.01 by two-way ANOVA. (b) Flow 
cytometric analysis of CD4+ cells (top) and CD4+Foxp3− cells (bottom) from spleen of 
wild-type mice, Pten-ΔTreg mice, and diseased Pten-ΔTreg mice. Representative of 10 
experiments. (c) Foxp3+ Tregs were isolated from wild-type, Pten-ΔTreg and diseased Pten-
ΔTreg mice and analyzed for expression of CD44, CD62L and ICOS. Representative of 10 
experiments. (d) Serum IgG1, IgG3a/c, IgG2b, IgG3, IgA and IgM concentrationss from the 
three groups of mice as defined above. n = 10 for diseased Pten-ΔTreg and 5 for other 
groups, representative of 3 experiments; *p < 0.0001, **p < 0.001, ***p = 0.0001 by one-
way ANOVA. (e) CD4+ cells from lymph nodes of control mice and diseased Pten-ΔTreg 
mice were isolated, restimulated ex vivo and stained for IFN-γ and IL-17, representative of 5 
experiments. (f) Hematoxylin and eosin staining of renal tissue from a representative wild-
type (top) and Pten-ΔTreg mouse (bottom); 10x magnification. (g) Serum creatinine 
concentrations in Pten-ΔTreg mice with age. n = 8, representative of 2 experiments. Red 
symbols indicate age at which visible lymphadenopathy occurred; red line indicates the level 
at which kidney failure is diagnosed in mice. (h) Anti-double stranded DNA antibody 
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concentrations in Pten-ΔTreg mice. n = 10, representative of 2 experiments; *p < 0.0001 by 
one-way ANOVA. All error bars shown are mean ± SD.
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Figure 3. 
Expansion of PTEN-deficient Tregs in vivo. (a) Wild-type and Pten-ΔTreg mice were injected 
i.p. with BrdU every 12 h for 3 consecutive days. Cells were isolated from thymus, spleen, 
pLN and mLN and assessed for BrdU incorporation. n = 9, representative of 4 experiments; 
*p < 0.001, **p < 0.002, ***p < 0.0001 by t-test. (b) Female Ptenfl/fl mice were bred to 
express one allele of Foxp3-Cre (Cre heterozygous mice) and followed over time along with 
female Pten-ΔTreg mice (homozygous for Foxp3-Cre). n = 20. (c) Flow cytometric analysis 
of peripheral blood CD4+Foxp3− T cells from mice as in panel b plus a wild-type Foxp3-
Cre control mouse. (d) Aged Ptenfl/fl Cre heterozygous female mice develop disease similar 
to Pten-ΔTreg mice with delayed onset, n = 20 (Cre het) or 35 (Pten-ΔTreg). All error bars 
shown are mean ± SD.
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Figure 4. 
Loss of PTEN prevents the ability of Tregs to resolve autoimmune inflammation. (a) Wild-
type and Pten-ΔTreg mice were immunized s.c. with myelin oligodendrocyte peptide 
emulsified in complete Freund’s adjuvant (CFA) to induce experimental autoimmune 
encephalomyelitis (EAE), and clinical disease severity was monitored for 35 days post-
immunization. n = 10, representative of 3 experiments; p < 0.0001 by two-way ANOVA. (b) 
Representative flow cytometric analysis for CD4 and Foxp3 in the spleen, draining lymph 
nodes and brain of mice in panel a at day 35. (c) T cells as in panel b were restimulated ex 
vivo and assessed for production of IFN-γ and IL-17. Left set of panels are gated on 
CD4+Foxp3− cells and the right set of panels are gated on CD4+Foxp3+ cells. n = 5, 
representative of 3 experiments. (d) Compilation of data from the experiments in c. N.D. = 
not detected; *p < 0.0001, **p < 0.001, ***p < 0.01 by two-way ANOVA. All error bars 
shown are mean ± SD.
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Figure 5. 
PTEN deficiency skews Treg metabolism toward glycolysis. (a,b) Tregs from Pten-ΔTreg and 
wild-type mice were purified and subjected to a glycolysis stress (a) or mito-stress test (b) to 
assess the bioenergetic profile of these cells. n = 3 samples per group, representative of 2 
experiments. (c) The indicated populations of cells were isolated from Pten-ΔTreg or wild-
type mice, stimulated and treated with [3-3H] glucose to measure the generation of 3H2O as 
an indicator of the glycolytic rate of cells. n = 4, representative of 3 experiments; *p < 0.01 
by two-way ANOVA. All error bars shown are mean ± SD.
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Figure 6. 
TSDR methylation analysis. Methylation status of CpG motifs of the Foxp3 locus was 
assessed by bisulfite sequencing of the indicated populations of sorted cells (data were 
averaged from 4 – 5 mice per group and > 76 total sequences per group).
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Figure 7. 
PTEN deletion leads to Treg instability in vitro. (a) CD4+Foxp3+CD25+ iTregs from Ptenfl/fl 
Foxp3GFP-hCre mice with indicated genotypes were sorted and cultured in the presence of 
IL-2 with or without the PI3K inhibitor (10 μM LY294002) for 6 d and expression of Foxp3 
and CD25 was monitored at indicated times. Representative of 3 experiments. (b) Foxp3+ 
cells were isolated from wild-type and Pten-ΔTreg mice, serum starved for 1 h and 
stimulated for 30 min in the presence of 200 IU/ml hIL-2. Cells were then immediately 
fixed, permeabilized and assessed for pSTAT5 levels by phospho-flow cytometry. Grey = 
isotype control. Representative of 3 experiments.
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Figure 8. 
PTEN deletion leads to Treg instability in vivo. Control and Pten-iΔTreg mice were treated 
with a 5 d course of tamoxifen as per Materials and Methods. Peripheral blood was assessed 
at the indicated time points. (a) Detection and quantification of ‘ex’-Foxp3 cells. All plots 
are gated on CD4+YFP+ cells, except Week -1, which is gated on total CD4+ cells. n = 5, 
representative of 3 experiments; *p <0.05, **p < 0.0001 by two-way ANOVA. (b) 
Expression of CD25 on Foxp3+ cells. CD25 staining of Foxp3+YFP+ Tregs (unshaded) and 
Foxp3+YFP− (shaded) unlabeled Tregs from a representative animal at week 20 as per panel 
a. n = 5, representative of 3 experiments, *p < 0.0001 by two-way ANOVA. (c) Expression 
of CD25 on ‘ex’-Foxp3 cells. CD25 staining of Foxp3−YFP+ (dashed) and Foxp3+YFP+ 
(solid) cells for the animal shown in panel b. n = 5, representative of 3 experiments; *p < 
0.0001 by two-way ANOVA. All error bars are mean ± SD.
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